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Abstract 
The high-affinity glycine transporter in neurons and glial cells is the primary means of inactivating synaptic glycine. The effects of 
12-O-tetradecanoylphorbol ester (TPA), a potent activator of protein kinase C (PKC), on the high-affinity Na+-dependent glycine 
transport were investigated in C6 cells, a cell line of glial origin. Incubation of C6 cells with TPA led to concentration- and 
time-dependent decrease in the glycine transport that could be completely suppressed by the addition of the PKC inhibitor staurosporine. 
The TPA effect could be mimicked by oleoylacetylglycerol and exogenous phospholipase C. Northern and Western blot analysis indicate 
that C6 cells express the GLYT1 glycine transporter. Incubation of COS cells transiently transfected with a full-length clone of the 
GLYT1 transporter in the presence of TPA, produces adecrease in glycine uptake. 
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1. Introduction 
Glycine is known to have two roles in neurotransmis- 
sion. In the spinal cord and brain stem glycine is an 
important inhibitory neurotransmitter hat opens C1- chan- 
nels in the postsynaptic cell, so keeping the membrane 
potential at a hyperpolarized state. In addition, glycine 
could potentiate the action of glutamate, the main excita- 
tory neurotransmitter in the brain, on postsynaptic N- 
methyl-D-aspartate (NMDA) receptors. 
It is generally well accepted that glial cells of the 
central nervous system play an important role in the 
modulation of neuronal excitability via control of the 
levels of neuroactive substances in the extracellular millieu 
of neurons [1-5]. The reuptake of neurotransmitter amino 
acids into presynaptic nerve endings or the neighbouring 
glial elements provides one way of clearing the extracellu- 
lar space of potential neuroactive substances, and so con- 
stitutes an efficient mechanism by which postsynaptic 
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action can be terminated. Specific high-affinity transport 
systems have been identified in glia for several amino acid 
neurotransmitters including glycine [6,7]. 
Within the past few years, some of the neurotransmitter 
transporters have been purified from mammalian brain 
[8-10], and more recently, cDNA clones encoding trans- 
porters for GABA, catecholamines, serotonin, glycine, glu- 
tamate and proline have been isolated [11-19]. After cDNA 
cloning techniques have been applied to the study of these 
proteins, transporters can now be classified into families 
and subfamilies based on topology and sequence related- 
ness [20-22]. To date, two different glycine transporters 
have been cloned. A glycine transporter (GLYT1) 
[18,20,23] which seems to colocalize mainly with NMDA 
receptors, and presents two isoforms produced by alterna- 
tive splicing or alternative promoter usage [24]. More 
recently, a second glycine transporter (GLYT2) [25], which 
is present specifically in the brain stem and spinal cord, 
brain areas where glycine receptors are more represented, 
has been cloned. 
Despite the rapid progress in this field, there is cur- 
rently very little information available about he regulatory 
possibilities of these proteins by hormones or second 
messengers. Recently, data by our group have demon- 
strated the regulation of GABA and glutamate transport 
through the activation of second messengers systems [26- 
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29]. These data, together with the presence of potential 
phosphorylation sites in the already cloned glycine carri- 
ers, led to the idea that intracellular signalling mechanisms 
and protein kinases may be involved in the regulation of 
glycine transporters in neurons or glial cells. 
In the present report we describe the effect of phorbol 
esters on the glycine transport activity in glioma cells and 
on the expressed GLYT1 transporter cDNA. 
2. Materials and methods 
2.1. Materials 
[2-3H]Glycine (1.76 PBq/mol) was obtained from the 
Du Pont-New England Nuclear, Boston, MA, USA. Dul- 
becco's modified Eagle's medium (DMEM) and fetal calf 
serum were obtained from Gibco, Paisley, UK. Dishes for 
tissue culture were purchased from Costar, Cambridge, 
MA. USA. BSA and phospholipase C from Bacillus cereus 
were from Boehringer, Manheim, Germany. 12-O-Tetrade- 
canoylphorbol 13-acetate (TPA), 1-oleoyl-2-acetyl-sn- 
glycerol (OAG), 4a-phorbol 12,13-didecanoate (PDD), and 
staurosporine were purchased from Sigma, St. Louis, MO, 
USA. All other reagents were of the highest purity avail- 
able. 
2.2. Cell culture 
C6 glioma cells, cloned originally from a rat glioma 
[30] and obtained from The American Type Culture Col- 
lection (Rockville, MD, USA), were maintained in mono- 
layer culture in DMEM containing 10% (v/v) horse serum 
and 2.5% (v/v) fetal-calf serum in 100 mm-diameter 
plastic dishes. They were maintained at37°C in humidified 
air with 5% CO 2. Cells were subcultured twice a week by 
standard procedures. The methods for harvesting and sub- 
culturing have been described previously [31]. For 
glycine-uptake experiments, cells were grown in 24-well 
tissue-culture plates to reach confluency. 
2.3. Expression in COS cells 
Transient expression of COS cells was carried out using 
DEAE-dextran with dimethyl sulfoxide according to the 
method of Kaufman [32] with minor modifications. COS 
cells were grown in 24-well plates at 37°C and 5% CO 2 in 
high glucose Dulbecco's modified Eagle's medium supple- 
mented with 10% bovine fetal serum, 100 U/ml  penicillin 
G, and 100 ~g/ml  streptomycin sulfate. Cells were rou- 
tinely used 2 days after transfection for transport studies. 
2.4. Transport assays 
glucose, 5 mM KC1, 1 mM MgCI 2, pH 7.4). All solutions 
used in the uptake experiments were prepared with dis- 
tilled deionized water and filtered through MiUipore filters 
(0.45 /xm pore size) to avoid possible bacterial contamina- 
tion. The osmolarity of all solutions was kept constant 
during the uptake experiments. Growth medium was re- 
moved by aspiration and after washing with Hepes-buffered 
saline medium, uptake was started by adding 300 /.d of 
Hepes-buffered saline medium containing radioactive 
glycine (0.2 /xM). Cells were incubated for the indicated 
time and then the experiments were terminated by washing 
the cells with three times 500/zl of ice-cold PBS medium 
(0.9 mM CaC12, 2.68 mM KC1, 1.47 mM KH2PO4, 0.49 
mM MgC12, 136.89 mM NaC1, 7.37 mM Na2HPO4, pH 
7.4). Cells were solubilized with 200 /zl of 0.1 M NaOH. 
Samples (125 /xl) were placed directly in microvials and 
their radioactivity was measured in a liquid scintillation 
counter (LKB 1219 Rackbeta). All incubations were car- 
ried out in triplicate. Each experiment was repeated at least 
three times with different cell cultures. For estimating 
statistical differences, the data were compared using the 
Student's t-test; differences at the 0.05 level were consid- 
ered statistically significant. 
2.5. cDNA cloning 
A cDNA corresponding to the 664 nucleotides close to 
the carboxyl terminus of the glycine transporter cDNA [18] 
was obtained by PCR using rat GLYT1 cDNA as template. 
The 5' sense strand oligonucleotide (5'-GGTGGGGAAT- 
GAGTGGATFCTGCAG-3') correspond to bases 1257 to 
1281. The 3' antisense oligonucleotide (5'-TGCTCA- 
TATCCGGGAGTCCTGGAGG-3') corresponds to bases 
1896 to 1920. The 664 bp amplified cDNA was blunt-end 
ligated to a Bluescript plasmid previously digested with 
Sinai. Inserts were sequenced by standard methods. 
2.6. RNA preparation and Northern blot analysis 
RNA was extracted from cells as described [33]. 10 ~g 
of total cellular RNA per lane were electrophoresed through 
a 1.3% agarose gel and transferred to Hybond N filters 
[34]. After blotting, the filters were hybridized with 32p_ 
labelled cDNA probes generated using the hexanucleotide 
random priming method [35]. Hybridization was carded 
out at 42°C for 12-16 h in a solution containing 50% 
formamide, 5 × SSC (0.15 M NaC1 and 0.015 M sodium 
citrate), 5 × Denhardt's olution and 0.1% SDS (sodium 
dodecylsulfate). The membranes were washed with 0.2 × 
SSC, 0.1% SDS at 42°C and exposed to X-ray film for 
3-5 days. Radioactivities of the positive bands were mea- 
sured by Molecular Dynamics Image Quant v. 3.0. 
2.7. Immunoblotting 
Assays were performed at 37°C in Hepes-buffered saline 
(150 mM NaCI, 10 mM Hepes, 1 mM CaC12, 10 mM 
Samples were transferred by electroblotting onto a 
nitrocellulose membrane in a semidry electroblotting sys- 
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Fig. 1. Time course of glycine uptake in glioblastoma cells. C6 cells 
grown to confluence were incubated at 37°C in the presence of 0.2 /zM 
of [2-3H]glycine in the following media: Hepes-buffered saline, control 
(with 150 mM NaC1) (O), and Hepes-buffered saline in which NaCI has 
been iso-osmotically replaced by LiC1 (O). Values represent means + S.E. 
of three duplicate xperiments. 
tern (LKB) at 1.2 mA/cm 2 for 2 h. The transfer buffer 
consisted of 192 mM glycine and 25 mM Tris-HC1, pH 
8.3. Nonspecific protein binding to the blot was blocked 
by the incubation of the filter with 3% non-fat milk protein 
in 10 mM Tris-HC1, pH 7.5, 150 mM NaC1 overnight at 
25°C. The blot was then probed with 1:200 dilution of 
antiserum produced against a fusion protein containing 76 
amino acids of the C-terminus of GLYT1 transporter, for 4 
h at 25°C. After washing, the blot was then probed with an 
antirabbit IgG peroxidase linked, and bands were visual- 
ized with the a-chloronaphthol method [36]. 
2.8. Protein determination 
Membrane proteins were determined according the 
method of Bradford [37]~ 
3. Results and discussion 
Fig. 1 is a time course showing uptake of glycine in C6 
glioblastoma cells at a concentration (0.2 /zM) which 
serves as substrate for the high-affinity glycine transport 
system with little involvement of the low-affinity compo- 
nents. The experiments were performed by measuring the 
initial rates of glycine transport corrected for non-saturable 
diffusion (non-specific transport). To make this correction, 
we used the experimental corrections described previously 
[38]. The uptake was almost completely Na+-dependent 
and increased linearly with time up to approx. 10 min. 
We have described a short-term regulation in the func- 
tion of GABA and glutamate transporters by phorbol esters 
acting through PKC [26,26]. Moreover, we have demon- 
strated that a glial glutamate transporter can be phospho- 
rylated both in vitro and in vivo by PKC and that this 
phosphorylation affects the transport of glutamate activity 
[29]. A long-tfrm regulation of the GABA transporter by 
cAMP has also been reported [28]. All these data, together 
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Fig. 2. Effects of TPA on Na+-dependent glycine uptake in glioblastoma 
cells. C6 cells were incubated in Hepes-buffered saline at 37°C in the 
presence of 0.1 gM TPA at the indicated times. Transport activity was 
measured for 10 min in the same medium containing 0.2 /zM of labelled 
glycine. Values represent means + S.E. of three duplicate xperiments. 
with the fact that the glycine transporters already cloned 
have several consensus sequences for protein kinase-medi- 
ated phosphorylation, led us to investigate a possible regu- 
lation of the high-affinity glycine uptake through PKC 
activation. 
The effect of the phorbol ester TPA on high-affinity 
glycine uptake was tested in C6 cells. Incubations of cells 
with TPA decreased glycine uptake in a time-dependent 
manner until approx. 1 h (Fig. 2). Exposure for additional 
time did not result in any further significant effect of TPA. 
A dose-response r lationship for the TPA effect on the 
high-affinity glycine transport in glioma cells demonstrates 
that uptake decreases with TPA concentration, reaching a
maximum of inhibition at approx. 0.1 /~M TPA (Fig. 3). 
To test the possibility that TPA-induced decrease in 
glycine uptake might be exerted through activation of 
Na+/H ÷ exchange, a known effect of PKC activation in 
many cell types [39], the effect of TPA was also studied in 
the presence of amiloride, an inhibitor of the Na+/H + 
exchange. The results how that the presence of amiloride 
does not significantly influence by itself or in the presence 
of TPA the uptake of glycine (29.2 + 1.5 pmol/10 min 
per mg of protein in the controls versus 30.1_ 1.2 
pmol/10 min per mg of protein in the presence of 100 
/zM amiloride). 
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Fig. 3. Effects of increasing concentrations of TPA on Na+-dependent 
glycine uptake in glioblastoma cells. C6 cells were incubated for 45 min 
at 37°C with TPA at the indicates concentrations. Transport activity was 
measured in the presence of 0.2 /,~M of [2-3H]glycine. Values represent 
means + S.E. of three duplicate xperiments. 
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The ability of phorbol esters to inhibit glycine uptake in 
glioblastoma cells correlates with the degree of specificity 
of TPA to stimulate PKC [40]. On the other hand, the 
concentrations of phorbol esters are consistent with their 
potency in binding and promoting PKC-stimulated events 
in neuronal cells and other tissues, and would imply that 
the effects of phorbol esters on glycine uptake in C6 cells 
are mediated through the activation of PKC. 
The effect of preincubation with staurosporine, a well 
known inhibitor of PKC [41], in the absence and the 
presence of TPA, on high-affinity glycine uptake in C6 
cells was examined (Table 1). The results show that the 
presence of staurosporine does not by itself affect the 
uptake of glycine; however, it prevents the induced de- 
crease of glycine uptake in the presence of TPA. Results in 
Table 1 also show that preincubation f cells with 4a-PDD, 
an inactive phorbol ester, had no effect on the glycine 
uptake. We also evaluated the effect of OAG, a permeant 
DAG analog which has been reported to stimulate PKC in 
several cell types [42], on glycine transport in glioma cells. 
As shown in Table 1, OAG exerted a similar inhibitory 
effect to that observed in the presence of phorbol esters. 
The addition of exogenous phospholipase C (0.02 
units/ml) mimic the inhibitory effect achieved in the 
presence of TPA or OAG. It has been reported that 
phospholipase C generates DAG from membrane phospho- 
lipids when added exogenously to a variety of cell types 
[43,44]. This would result in an increase in intracellular 
Ca 2+ and activation of PKC through second messengers 
inositol trisphosphate and DAG, respectively. 
C6 cells seem to express mainly the GLYT1 transporter 
system, as we have shown previously that high-affinity 
uptake of glycine in C6 is competitively inhibited by 
sarcosine [38], a characteristic that is not shown by the 
GLYT2 transporter subtype [26]. To define the presence or 
Table 1 
Effects of TPA, staurosporine, 4ot-PDD, OAG, and phospholipase C on 
sodium-dependent glycine uptake in glioblastoma cells 
Conditions Sodium-dependent 
glycine uptake 
(pmol/mg protein per 10 min) 
Control 27.1 + 1.5 
Staurosporine 29.0 ± 0.4 
TPA 15.8 _+ 1.0 a 
TPA + staurosporine 26.9 _+ 0.5 
4ot-PDD 27.0 + 1.7 
OAG 16.7 ± 0.9 a 
Phospholipase C 9.4 + 1.0 b 
C6 glioblastoma cells were incubated for 30 min at 37°C in the presence 
of either TPA (1.0 /zM), 4ot-PDD (1.0 gM), OAG (50 /xg/ml) or 
phospholipase C (0.02 U/ml)  or its solvent at an equivalent concentra- 
tion. When staurosporine was used, was added and incubated for 30 min 
at 37°C before the addition of TPA. The glycine transport assay was 
carded out for 10 rain in Hepes-buffered saline in the presence of 0.2 
/zM labelled glycine. Values represent the means 4-S.E. of three different 
duplicate xperiments. They were compared with the control value by 
Student's t-test Values a p < 0.01; b p < 0.001. 
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Fig. 4. Expression of the GLYT1 transporter in C6 glioblastoma cells. (A) 
Total RNA (10 /xg) from C6 cells was extracted and analyzed by 
Northern blot as indicated in Materials and methods. The membrane was 
probed with a eDNA from the GLYT1 transporter. (B) A membrane 
fraction from glioblastoma cells was analyzed by immunoblotting as 
indicated in Materials and methods. 
not of the mRNA encoding the glycine transporter GLYT1 
we carried out Northern blot analysis of total RNA isolated 
from C6 glioblastoma cells. A single transcript of 3.8 kb 
which hybridized at high stringency with the GLYT1 
cDNA probe can be observed in the Fig. 4A. Fig. 4B 
shows immunoblotting data with a polyclonal antibody 
raised against a fusion protein containing 76 amino acids 
of the C terminus of GLYT1 transporter (L. Olivares, C. 
Arag6n, C. Gim6nez and F. Zafra, unpublished ata). 
When a membrane fraction from glioblastoma cells was 
probed with this antibody, abroad band of approx. 70-100 
kDa lip up. 
Next, we tested the possible modulatory action of phor- 
bol esters in COS cells transiently transfected with rB20a 
(a full-length clone of GLYT1 in the eukaryotic expression 
vector pSVL) [18]. COS cells transiently transfected with 
rB20a accumulated more glycine than nontransfected con- 
trol cells (Fig. 5). The same figure shows that incubation 
of transfected COS cells in the presence of the phorbol 
ester TPA produced a decrease in glycine uptake in a 
time-dependent form until approx. 1 h. Exposure for addi- 
tional time did not result in any further significant effect of 
TPA. 
A dose-response r lationship for the TPA effect on the 
high-affinity glycine transport in COS-transfected cells 
(Fig. 6) demonstrates that uptake decreased with TPA 
concentration, reaching a plateau at approx. 0.1 /xM TPA. 
Taking together all these data, it is possible to establish 
that the high-affinity glycine uptake in glioblastoma cells 
can be regulated by second messenger systems. Results 
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Fig. 5. Effect of TPA on glycine transport in COS cells transfected with 
clone rB20a. Nontransfected COS cells (©) or COS cells transfected with 
rB20a (0 )  were preincubated for the indicated time in the presence of 0.1 
/xM TPA. The transport assay was carried out during 5 rain at 37°C in the 
presence of 0.2 /xM labelled gtycine. (11) Represents the difference 
between transport in transfected and nontransfected COS cells. Values 
represent means + S.E. of three duplicate xperiments. 
demonstrating that neurotransmitter transporters can be 
regulated are important because there is currently very 
little information available on the regulatory aspects of 
these proteins. Apart of the role of PKC on the GABA and 
glutamate shown by our group [26,27,29], a similar modu- 
latory effect has been shown in the serotonin transporter 
function in endothelial cells by PKC [45]. On the other 
hand, it has been reported the involvement of cAMP in the 
long-term modulation of GABA (GAT-1) transporter from 
rat brain [28], and a high-affinity serotonin transporter in
the human placental choriocarcinoma cell line [46]. 
The exact mode of glycine transport regulation by PKC 
remains to be elucidated. Although a direct phosphoryla- 
tion has been demonstrated in a glial glutamate transporter 
by PKC [29], other alternative mechanisms cannot be ruled 
out. The observed effect could be indirectly mediated by 
changing the activity of ion channels or the Na+/K ÷- 
ATPase function which could alter ion concentration both 
inside and outside of a cell [47]. 
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Fig. 6. Effect of increasing concentration f TPA on glycine transport in 
COS cells transfected with clone rB20a. COS cells transfected with rB20a 
were incubated for 30 min at 37°C with TPA at the indicated concentra- 
tions. Transport activity was measured in the presence of 0.2 /zM 
labelled glycine. Values represent means + S.E. of three duplicate xperi- 
ments. 
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